Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lupus erythematosus, systemic
Symptom C0042373|vascular disease
Sentences 22
PubMedID- 24658835 Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
PubMedID- 20191526 Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle).
PubMedID- 22401784 Subclinical vascular disease in patients with systemic lupus erythematosus: the additive deleterious effect of the antiphospholipid syndrome.
PubMedID- 24470118 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.
PubMedID- 26354963 Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
PubMedID- PMC3467499 Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle).
PubMedID- 23942785 Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
PubMedID- 21360503 Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation.
PubMedID- 22126778 Objective: to investigate the prevalence of cardiovascular diseases (cvd) in patients with systemic lupus erythematosus (sle) and estimate the associated risk factors for cvd.
PubMedID- 23052654 Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus.
PubMedID- 24787906 Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
PubMedID- 23612403 Cerebrovascular disease in women with systemic lupus erythematosus.
PubMedID- 22210142 Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
PubMedID- 25379191 Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus.
PubMedID- 25732129 Results: plasma sucrose non-fermenting ampk related kinase and pentraxin 3 concentrations were increased in systemic lupus erythematosus cases with cardiovascular disease compared to systemic lupus erythematosus controls and healthy controls (p < 0.0001).
PubMedID- 22957213 vascular disease in systemic lupus erythematosus.
PubMedID- 24299152 Altered levels of fxiia-serpin complexes in systemic lupus erythematosus (sle) patients with previous vascular disease (vd).
PubMedID- 24790989 Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.
PubMedID- 25638414 Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.
PubMedID- 25182169 Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts.
PubMedID- 24452079 A rare form of vascular disease in systemic lupus erythematosus (sle), lupus vasculopathy is characterized by necrosis and accumulation of immunoglobulins (igs) and complements in the wall of arterioles and small arteries resulting in luminal narrowing.
PubMedID- 22174200 Association between depression and vascular disease in systemic lupus erythematosus.

Page: 1